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introduCtion
Diffuse intrinsic pontine glioma (DIPG) is an almost invariably fatal brain neoplasm affecting mainly children, with a two-year survival rate less than 10% 1, 2 . Its hallmarks are the specific anatomical location from which it originates, the pons 3 , its diffuse phenotype, often spreading to the cerebellum and brain areas as far as the cerebral hemispheres 4 , and its bleak prognosis 3 . Despite various clinical trials, the standard treatment for DIPG patients remains conventional radiotherapy (RT), which provides transient neurological improvement, resulting in a better quality of life, but does not improve probability of overall survival 1, 2, 5 . Therefore, novel treatment strategies to increase effectivity of RT in DIPG are urgently needed.
We have previously shown that inhibition of WEE1 kinase, one of the main gatekeepers of the G 2 cell cycle checkpoint, is a potential therapeutic target for radiosensitization of adult gliomas 6 and of other type of cancers [7] [8] [9] . Normal cells have functional cell cycle checkpoints as compared to cancer cells, which often have a deficient G 1 arrest due to aberrant p53 signaling and hence heavily rely on the G 2 checkpoint to repair DNA damage caused by irradiation (IR) 10 . Abrogation of the G 2 checkpoint pushes glioma cells with unrepaired DNA damage into mitotic catastrophe, resulting in subsequent cell death 11 . Interestingly, in DIPG, recent genomic studies have revealed aberrations in genes regulating the G 1 checkpoint, including TP53, MDM2, CDKN2A, ATM [12] [13] [14] [15] [16] [17] [18] [19] , suggesting a dysfunctional G 1 arrest in DIPG cells. Therefore, inhibition of WEE1 could be a potential strategy to enhance the response to IR in DIPG cells.
A number of small molecule compounds that inhibit WEE1 have been developed.
These include PD0166285 20, 21 , PD0407824 22, 23 , WEE1 inhibitor II and PHCD [23] [24] [25] . The most promising WEE1 inhibitor may be MK-1775, a pyrazolo-pyrimidine derivative, because of its selectivity and potency to inhibit WEE1 kinase 26, 27 . In vivo, WEE1 inhibition has resulted in tumor growth reduction, increased survival and absence of significant toxicity in several studies utilizing xenograft animal models 6, 9, [26] [27] [28] [29] [30] . Moreover, preliminary results of a phase I study of oral MK-1775 as monotherapy and in combination with gemcitabine, cisplatin, or carboplatin reported good tolerance and strong target engagement 31 .
We have previously shown that inhibition of WEE1 could function as a potential radiosensitizer of adult gliomas, both in vitro and in vivo. As an extension to these previous results, in this study, we investigated the potential radiation enhancing effects of a more potent and clinically relevant WEE1 inhibitor, MK-1775, in DIPG cells in culture and in vivo using the E98-Fluc-mCherry (E98-FM) DIPG mouse model, closely resembling the DIPG phenotype in humans 32 .
materials and metHods

Ethics statement
All animal experiments were performed according to the guidelines established by the European community and following a protocol (NCH10-05) approved by the institutional ethical committee on animal experiments of the VU University. All patient samples including the de novo cell line VUMC-DIPG-A were used after appropriate written informed consent and under approval of the institutional medical ethical committee of the VU University Medical Center (VUmc). The here-described research has been conducted according to the principles expressed in the Declaration of Helsinki.
In silico analysis of DIPG kinase expression 
Cells and tissue samples
The primary low passage VUMC-DIPG-A cells were derived from tumor tissue surgically removed from a patient diagnosed with DIPG at the VUmc. E98 cells were obtained from Radboud University Nijmegen Medical Centre (Nijmegen, the Netherlands) 34 and transduced with a lentiviral vector containing Fluc and mCherry at our institution 32 . Cells used in this study were not authenticated. The primary VUMC-DIPG-A and E98-FM cells were cultured in DMEM medium (PAA, Cölbe, Germany) containing 10% FBS, and antibiotics. DIPG tissue and control non-neoplastic brain tissue were obtained postmortem from five DIPG patients (VUMC-DIPG-1, 2, 3, 4, and 5) 35 , while VUMC-DIPG-A cells were isolated from surgical specimen after written informed consent.
WEE1 inhibitor and IR
The WEE1 inhibitor MK-1775 (Axon Medchem, Groningen, The Netherlands) was resuspended in DMSO to a concentration of 100 mM and diluted in PBS for the in vivo experiments and in medium for the in vitro experiments. Cells were irradiated in a Gammacell® 220 Research Irradiator (MDS Nordion).
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Western blotting
Immunofluorescence staining
Cells were fixed in 3% paraformaldehyde at different time points post-irradiation (15 min, 30 min, 1, 24, 48, 72 hrs). Prior to staining, the cells were rinsed in PBS and permeabilized in PBS containing 0.1% Trition X-100 for 30 min at room temperature and blocked in PBS containing 5% FCS. Cover slips were incubated with both mouseanti-γ-histone-H2AX (1:100) (Millipore) and rabbit-anti-53BP1 (1:100) (Novus Biologicals, Littleton, CO, USA) in PBS containing 5% FCS overnight at 4°C. This was followed by secondary antibody incubation with goat-anti-rabbit/Alexa568 immunoglobulins (1:100) (Invitrogen) and, subsequently, with rabbit-anti-mouse/FITC immunoglobulins (1:100) (DAKO) both in PBS containing 5% FCS for 30 min at room temperature in the dark. Slips were rinsed in PBS three times and nuclei were stained with DAPI (1:10,000)
in PBS at room temperature in the dark. This was followed by successive rinses in PBS and sterile water. The slips were then mounted on glass slides using Vectashield (Vector Laboratories, Burlingame, CA, USA) and analyzed with a Carl Zeiss Axioskop 20 microscope at 100x objective.
Cell counts
At four days after treatment, cells were fixed with 3.7% formaldehyde and DNA was stained with DAPI (0.3 µg/ml). Cell numbers were assessed by counting the number of DAPI-stained cells using the Acumen Ex3 laser scanning cytometer (TTP LabTech, Royston, UK).
In vivo analysis using the orthotopic E98-FM DIPG mouse model
Female athymic nude mice (age six-eight weeks; Harlan, Zeist, the Netherlands)
were kept under specific pathogen-free conditions in air-filtered cages and received food and water ad libitum. E98-FM cells were injected as described elsewhere 32 . In short, tumors were generated via stereotactic injection of 0. (Fig. 1A) . Using one-way analysis of variance (ANOVA), WEE1 mRNA levels were determined to be significantly higher in DIPG than in different regions of normal control brain. Interestingly, WEE1 mRNA levels were significantly higher in DIPG as compared to LGG of the brainstem, as we previously observed in adult low and high-grade gliomas 6 .
WEE1 protein is overexpressed in DIPG patient material and cell lines
Next, we analyzed the protein expression of WEE1 kinase by WB in five different postmortem DIPG tissues 35 isolated from the pons and matched these to non-neoplastic brain tissues of the same patient (Fig. 1B) . We observed significant overexpression of WEE1 protein in 4 out of 5 tumors as compared to the non-neoplastic brain tissues.
For patient VUMC-DIPG-1 we were not able to detect WEE1 protein overexpression in the tumor in the pons region, which may be due to the presence of tumor necrosis in the sample used. However, we detected significant WEE1 protein expression in VUMC-DIPG-1 tissue isolated from the frontal lobe of the same patient (Fig. 1B) . In addition, we analyzed WEE1 protein expression by WB in a primary DIPG cell line and in E98-FM glioma cells 32 , again demonstrating significant WEE1 protein levels (Fig. 1C) .
Furthermore, by IHC we found WEE1 protein overexpression, as shown by a clear nuclear staining, in DIPG tumors located in the pons (Fig. 1D -G and 1I-K left panels)
as compared to matched non-neoplastic brain tissue (Fig. 1L ). In particular, high levels of WEE1 were detected in the tumor bulk (Fig. 1D, asterisk) , as well as in the infiltrative DIPG component (Fig. 1E) , and in tumor cells surrounding blood vessels (Fig. 1F) . Top 20 up-regulated kinases in DIPG tumor samples (n=27) 17 sorted on log2 fold increase as compared to nonmalignant brain tissues (n=174) 33 including two samples of normal brain stem tissue from the DIPG dataset 17 . Wee1 homolog (WEE1) is identified as a highly differentially overexpressed kinase in DIPG.
Nuclei in the leptomeningeal tumor component also revealed WEE1 nuclear staining (Fig. 1G) . Of note, WEE1 was found to be overexpressed in tumor cells invading brain areas beyond the brainstem (Fig. 1H and 1I-K right panels) . Finally, clear WEE1 nuclear staining was also detected in tumor tissue derived from the orthotopic E98-FM DIPG mouse model (Fig.1M, arrow) . 
MK-1775 inhibits WEE1-regulated CDC2, IR-induced G 2 arrest, and repair of IR-induced DNA damage in DIPG cells
E98-FM and VUMC-DIPG-A cells were used to study the effect of the WEE1 kinase inhibitor MK-1775 in vitro. Since WEE1 phosphorylates CDC2 upon IR [37] [38] [39] , we performed WB analysis for phosphorylated CDC2 (Y15) 16 hrs after treatment with 0.1 µM MK-1775
and IR (Fig. 2B ). IR at 6 Gy resulted in increased CDC2-p Y15 levels, which were reduced upon treatment with MK-1775, indicating functional inhibition of WEE1 kinase activity in these cells. The effect of MK-1775-mediated WEE1 inhibition on the IR-induced G 2 arrest was determined by cell cycle analysis using flow cytometry (Fig. 2C) . In both cell lines, IR at 6 Gy induced a G 2 /M arrest after 16 hrs, indicated by an accumulation of cells with doubled DNA content and indicative for a dysfunctional G 1 arrest, which was reduced upon treatment with 0.1 µM MK-1775. Subsequently, we examined the effect of WEE1 inhibition on the repair of IR-induced DNA damage within these cells ( Fig. 2D and E) .
The IR-induced DNA damage was visualized using the DNA double strand break (DSB) markers γH2AX and 53BP1 at 15 min, 30 min, and 1, 24, 48, and 72 hrs after treatment with IR at 4 Gy in the presence or absence of 0.1 µM MK-1775. As shown in Figure 2D γH2AX and 53BP1 colocalize. These results indicate DNA damage in both cell lines after IR treatment as compared to untreated cells. Cells treated with IR showed fast onset of DSBs (as early as 15 min after IR), however, a decreased number of γH2AX and 53BP1 foci was observed over time in cells treated only with IR, indicating the occurrence of DNA damage repair within these cells ( Fig. 2D and E) . Of note, although no differences in the number of IR-induced DSB foci were observed at the early time points after IR, the cells However, combined treatment with MK-1775 and IR resulted in additional diminished cell viability, as compared to IR alone (p<0.05) (Fig. 3C and D) . respectively) ( Fig. 4A and B) . Moreover, the mean BLI signal of the irradiated MK-1775-treated group was significantly decreased compared to the irradiated group at week 4 after injection of the cells (p<0.05). In addition, survival analysis showed a significant advantage for combining IR with MK-1775 over the vehicle-treated control group (logrank, p<0.05), whereas the groups receiving only MK-1775 or IR showed no significant effect on survival as compared to the untreated mice (Fig. 4C) . These results indicate Kinase expression data analysis showed WEE1 kinase to be in the top-10 overexpressed kinases in a dataset of DIPG samples compared to normal brain tissues. Although the other overexpressed kinases could also be of value for investigating therapeutic targeting in DIPG, we analyzed WEE1 kinase, since it was previously demonstrated to be a potential target for the radiosensitization of adult glioma cells 6 , and because a clinically relevant WEE1 inhibitor was available 31 . We found WEE1 to be highly overexpressed in the DIPG tissues analyzed. Interestingly, WEE1 was also overexpressed in tumor tissue invading brain areas beyond the brainstem (including cerebellum, insula, and frontal lobe), indicating that the infiltrative DIPG components can also be potentially targeted Hence, the limited radiation enhancing effect observed on DIPG in vivo may also be attributable to a possible inability of MK-1775 to cross the blood brain barrier, which may be intact in large parts of the DIPG tumor 32 .
In conclusion, in this study we showed that WEE1 is overexpressed in DIPG and that its inhibition in vitro and in vivo resulted in additional anti-tumor effects when combined with IR. Ultimately, DIPG is a very aggressive and heterogeneous tumor and the development of a clinical multi-target approach will be necessary. In this context, WEE1 inhibition in conjunction with RT may be one of the therapeutic strategies employed in the treatment armamentarium needed to treat this now still fatal disease. reFerenCes
